Author

I. Nissen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:ATAC-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

S. Remeseiro· 2 shared A. Arner· 1 shared A. Hornblad· 1 shared A. Kahsay· 1 shared C. A. Vincent· 1 shared F. Pedrosa Domellof· 1 shared H. Nord· 1 shared J. Liu· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

S. Remeseiro

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

fhl2b expression ameliorates muscular dystrophy

N. Dennhag, A. Kahsay, I. Nissen, M. Chermenina, H. Nord, J. Liu, A. Arner, J.-X. Liu, L. J. Backman, S. Remeseiro, J. von Hofsten, F. Pedrosa Domellof

This study identifies fhl2b as a protective gene that ameliorates muscular dystrophy in zebrafish by rescuing muscle phenotype and improving survival.

bioRxiv · Oct 26, 2023 · PreprintCell Biology

Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide

C. A. Vincent, I. Nissen, A. Hornblad, S. Remeseiro

This study shows that perturbing novel EGFR enhancers reduces glioblastoma cell proliferation and invasion while increasing sensitivity to temozolomide.

bioRxiv · Feb 22, 2023 · PreprintCancer Biology